The invention discloses a
nadroparin calcium preparation technology. The technology comprises the steps of degradation liquid preparation, reducing liquid preparation,
precipitation, oxidation,
ion exchange, crude
nadroparin calcium preparation, refining, and lyophilization. The technology which adopts a chemical degradation method to produce
nadroparin calcium allows the highest nadroparin
calcium yield to reach 75%, and has the advantages of simplicity, abundant sources of raw materials, convenient operation, no
discharge of three wastes, low cost, and stable and controllable product quality.
Heparin fragments having different molecular weights are separated through membrane separation to prepare the nadroparin
calcium product having an anti-Xa
titer of 95-130IU / mg, an activity ratio of 2.5-4.0 and a molecular weight of 3600-5000D, and the product can reach the
quality standard prescribed in European
Pharmacopoeia. The product can reduce the local
hematoma phenomena and obviously improve the ache condition during
hypodermic injection, has the efficacies of venous thromboembolism prevention,
coronary heart disease treatment, anticoagulation,
antithrombotic property, antitumor, anti-
inflammation, anti-
allergy and blood fat adjustment, and has the advantages of substantial curative effects, wide application range and convenience for the large scale production.